Investor relations
Stock price
Annual report
Quarterly earnings
Financial reconciliations
SEC filings
Corporate governance
Analyst list
Investor events
Investor kit
Investor FAQ
Contact investor relations
investors : investor kit
Our 2006 and 2005 Annual Reports and associated marketing supplements are available in PDF format.* All can be viewed with Acrobat Reader.
2006 Annual Report in PFD format* (2.0 mb)
Therapeutic Overview - Supplement to 2006 Annual Report in PDF format* (4.46 mb)
2005 Annual Report in PDF format* (1.1Mb)
Global Capabilities Brochure - Supplement to 2005 Annual Report in PDF format* (288K)

Investor Presentation

Investor Presentation in PowerPoint

Investor Fact Sheet

Our Investor Fact Sheet contains quarterly market data, company facts, business overview, significant recent events, financial and operational results, and analyst coverage.

Investor Fact Sheet in PDF*

*PDF files require Adobe Acrobat Reader

Board of Directors (BOD)

Candace Kendle, PharmD, co-founded the company in 1981 and has served as Chief Executive Officer since its incorporation. She has been Chairman of the Board since 1991. From 1979 through 1981, Dr. Kendle held senior faculty positions in the pharmaceutical programs of several leading institutions. More recently, she has played a key role in the development of the master of science program in global drug development at the University of Cincinnati. Dr. Kendle serves as a director of H. J. Heinz Company, a food products manufacturer. She is the wife of Christopher C. Bergen, President and Chief Operating Officer of the company.
     
  Christopher C. Bergen, co-founded the company in 1981 and since its incorporation has served as a director and its President and Chief Operating Officer. From 1977 to 1981, Mr. Bergen served in various capacities at The Children's Hospital of Philadelphia, most recently as Associate Vice President. He is the husband of Candace Kendle, Chairman and Chief Executive Officer of the company.
     
  Robert R. Buck was re-appointed as a director of Kendle in June 2003. Mr. Buck previously served as a director of the company from 1998 through August 2002. He currently serves as President and Chief Executive Officer of Beacon Roofing Supply, Inc. Prior to joining Beacon, Mr. Buck served in a number of management and senior management positions with Cintas Corporation from 1982 through January 2003, most recently as President of its Uniform Rental Division.
     
  G. Steven Geis, PhD, MD, has served as a director of Kendle since November 2002. Now retired, Dr. Geis served in a number of senior R&D positions with Pharmacia & Upjohn Company from 1985 to July 2002, most recently as Group Vice President: Arthritis, Cardiovascular and Oncology Clinical Development.  He currently operates his own consulting firm assisting biopharmaceutical companies with their drug development programs.  Dr. Geis has authored or co-authored numerous journal articles covering several therapeutic areas.
     
  Donald C. Harrison, MD,has served as a director of Kendle since November 2001. He is Senior Vice President and Provost for Health Affairs Emeritus at University of Cincinnati. Dr. Harrison formerly served as the Senior Vice President and Provost for Health Affairs at University of Cincinnati from 1986 through 2002 and also served as the Chief Executive Officer of the University of Cincinnati Medical Center. He also is a practicing cardiologist on a part-time basis. Dr. Harrison's professional experience includes 26 years at Stanford University School of Medicine and Stanford University Hospital, where he was Chief of Cardiology from 1967 to 1968. He is past national President of the American Heart Association and has served as a director for several not-for-profit organizations. Dr. Harrison also serves as a director for start-up medical device and biotechnology companies, including UMD, Inc., Medical Education and Consultation Inc.; AtriCure, Inc.; and EnteroMedics, Inc. Since 2004, he has been a general partner in Charter Life Sciences, a California-based venture capital firm, for which he manages the Cincinnati office.
     
  Timothy E. Johnson, PhD, has served as a director of Kendle since November 2002. Dr. Johnson is a Professor of Finance at the University of Cincinnati and a Financial and Investment Consultant, serving as President of Johnson Investment Counsel, Inc. since 1965. Johnson Investment Counsel, Inc. is a registered investment adviser with the Securities and Exchange Commission (the "Commission") and manages portfolio assets for endowments, foundations, corporations, individuals and pension and profit sharing plans.  Dr. Johnson serves as a director or trustee for several civic and nonprofit organizations. He has written several textbooks and articles on investment and financial management.
     
  Frederick A. Russ, PhD, has served as a director of Kendle since November 2002. Dr. Russ is Senior Vice Provost at the University of Cincinnati, a position he has held since 2004. Prior to that he served for 10 years as Dean of the College of Business for the university. He previously served as non-executive Chairman of the Board of Charles & Colvard, Ltd. [CTHR], a manufacturer and distributor of moissanite jewels for use in jewelry sold around the world, and remains on its Board of Directors. Dr. Russ also serves as a director of the Economics Center for Education & Research and is a former member of
the board of Cree [CREE], an advanced materials company he helped found, and Techsolve, a not-for-profit serving manufacturing clients. He has co-authored three textbooks and numerous articles on marketing strategy and the behavior of consumers and sales personnel.